MB
Mirror Biologics, Inc.
mirrorbio.com
Website unreachable since Oct 24, 2026
The startup develops immunotherapy drugs that utilize living immune cells to modulate the human immune system for targeted cancer and infectious disease treatment. Their approach aims to provide patients with cost-effective, life-extending therapies that enhance quality of life.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$31.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops immunotherapy drugs that utilize living immune cells to modulate the human immune system for targeted cancer and infectious disease treatment. Their approach aims to provide patients with cost-effective, life-extending therapies that enhance quality of life.